Sanara Medtech Inc (SMTI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.78 is considered Undervalued compared with the five-year average of -9.03. The fair price of Sanara Medtech Inc (SMTI) is between 31.73 to 72.42 according to relative valuation method. Compared to the current price of 20.48 USD , Sanara Medtech Inc By Undervalued By 35.45%.

Relative Value

Fair Zone

31.73-72.42

Current Price：20.48

35.45%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Sanara Medtech Inc (SMTI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Sanara Medtech Inc (SMTI) has a current Price-to-Book (P/B) ratio of 33.55. Compared to its 3-year average P/B ratio of 10.03, the current P/B ratio is approximately 234.65% higher. Relative to its 5-year average P/B ratio of 9.07, the current P/B ratio is about 269.93% higher. Sanara Medtech Inc (SMTI) has a Forward Free Cash Flow (FCF) yield of approximately -0.41%. Compared to its 3-year average FCF yield of -0.98%, the current FCF yield is approximately -58.51% lower. Relative to its 5-year average FCF yield of -1.49%, the current FCF yield is about -72.66% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for SMTI competitors is 4.29, providing a benchmark for relative valuation. Sanara Medtech Inc Corp (SMTI.O) exhibits a P/S ratio of 1.78, which is -58.39% above the industry average. Given its robust revenue growth of 21.51%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of SMTI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of SMTI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is SMTI currently overvalued or undervalued?

What is Sanara Medtech Inc (SMTI) fair value?

SMTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Sanara Medtech Inc (SMTI) is between 31.73 to 72.42 according to relative valuation method.

How does SMTI's valuation metrics compare to the industry average?

The average P/S ratio for SMTI's competitors is 4.29, providing a benchmark for relative valuation. Sanara Medtech Inc Corp (SMTI) exhibits a P/S ratio of 1.78, which is -58.39% above the industry average. Given its robust revenue growth of 21.51%, this premium appears sustainable.

What is the current P/B ratio for Sanara Medtech Inc (SMTI) as of Mar 03 2026?

As of Mar 03 2026, Sanara Medtech Inc (SMTI) has a P/B ratio of 33.55. This indicates that the market values SMTI at 33.55 times its book value.

What is the current FCF Yield for Sanara Medtech Inc (SMTI) as of Mar 03 2026?

As of Mar 03 2026, Sanara Medtech Inc (SMTI) has a FCF Yield of -0.41%. This means that for every dollar of Sanara Medtech Inc's market capitalization, the company generates -0.41 cents in free cash flow.

What is the current Forward P/E ratio for Sanara Medtech Inc (SMTI) as of Mar 03 2026?

As of Mar 03 2026, Sanara Medtech Inc (SMTI) has a Forward P/E ratio of 19.91. This means the market is willing to pay $19.91 for every dollar of Sanara Medtech Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Sanara Medtech Inc (SMTI) as of Mar 03 2026?

As of Mar 03 2026, Sanara Medtech Inc (SMTI) has a Forward P/S ratio of 1.78. This means the market is valuing SMTI at $1.78 for every dollar of expected revenue over the next 12 months.

SMTI Valuation